» Articles » PMID: 17145878

A Small Interfering CD147-targeting RNA Inhibited the Proliferation, Invasiveness, and Metastatic Activity of Malignant Melanoma

Overview
Journal Cancer Res
Specialty Oncology
Date 2006 Dec 6
PMID 17145878
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

CD147 plays a critical role in the invasive and metastatic activity of malignant melanoma cells by stimulating the surrounding fibroblasts to express matrix metalloproteinases and vascular endothelial growth factor. We developed a system that blocks CD147 in the human malignant melanoma cell line, A375, using RNA interference. By transfecting melanoma cells with the small interfering RNA (siRNA) that targets human CD147, we were able to establish two stable clones in which CD147 expression was significantly down-regulated. This resulted in the decreased proliferation and invasion of A375 cells in vitro. CD147 siRNA also down-regulated the expression of vascular endothelial growth factor in these cells and reduced the migration of vascular endothelial cells. The reduction in the CD147 level suppressed the size of s.c. tumors and the microvessel density in an A375 s.c. nude mouse xenograft model. In addition, the in vivo metastatic potential of A375 cells transfected with CD147 siRNA was suppressed in a nude mouse model of pulmonary metastasis.

Citing Articles

Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers.

Chupradit K, Muneekaew S, Wattanapanitch M Cancer Immunol Immunother. 2024; 73(9):170.

PMID: 38954079 PMC: 11219683. DOI: 10.1007/s00262-024-03759-6.


Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y Signal Transduct Target Ther. 2024; 9(1):55.

PMID: 38453898 PMC: 10920854. DOI: 10.1038/s41392-024-01769-5.


CD147/Basigin Is Involved in the Development of Malignant Tumors and T-Cell-Mediated Immunological Disorders via Regulation of Glycolysis.

Kanekura T Int J Mol Sci. 2023; 24(24).

PMID: 38139173 PMC: 10743398. DOI: 10.3390/ijms242417344.


Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis.

Liu N, Yan M, Tao Q, Wu J, Chen J, Chen X J Immunother Cancer. 2023; 11(9).

PMID: 37678921 PMC: 10496672. DOI: 10.1136/jitc-2023-007146.


Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma.

Xu Y, He H, Wu P, Li W World J Gastrointest Oncol. 2023; 15(8):1412-1423.

PMID: 37663949 PMC: 10473926. DOI: 10.4251/wjgo.v15.i8.1412.